MEDTR.E.IS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 11, 2025
Report Source: 2025 1st Quarter Report

Meditera Tibbi Malzeme Sanayi ve Ticaret AS. Stock Analysis MEDTR.E.IS
Meditera Tibbi Malzeme Sanayi ve Ticaret AS engages in manufacturing medical devices. The firm is specialized in the manufacture of anesthesia and intensive care circuits, the installation, operation and design of oncology drug preparation and delivery systems, production, sales and technical service of infusion pumps and sets, and the manufacture of biocidal products. Meditera Tibbi Malzeme manufactures surgical sutures and breathing circuits and accessories through its joint venture subsidiaries which established with Internacional Farmaceutica and S&Mohr. Additionally, The Company provides technical service, maintenance, and calibration services related to medical devices.
Read More Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR.E.IS) Chart
Key Statistics of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR.E.IS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
TRY31.26Volume
687.10KP/E Ratio (TTM)
-52 Week Range
Market Cap
3.59BAvg. Volume
1.08MDividend Yield
1.02%Financial Metrics & Statements of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR.E.IS)
FAQ's for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR.E.IS)
- According to Musaffa’s Shariah screening methodology, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR.E.IS) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.